Skip to Content

Event Details

cfc ad


EPIDIOLEX® (cannabidiol) Oral Solution for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome, Dravet Syndrome, and Tuberous Sclerosis Complex

Contact Name:   Monica Graziosi

Contact E Mail:

Event Type: Webinar

Date: July 19, 2022

Time: 3:00 pm (EST)

Kendra L. Davies, PharmD, RPh

Sponsor by: Jazz Pharmaceuticals

Presentation will include an overview of Syndromes with Refractory Epilepsy (Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS) & Tuberous Sclerosis Complex (TSC)), a brief introduction of Cannabinoid Science, a description of EPIDIOLEX Randomized Controlled Trials and EPIDIOLEX Labeling Information

Register Now!

This webinar is complimentary for members and non-members

Connect with AAIDD on Social Media

Join The AAIDD Email List

Annual Conference